Search clinical trials for: Granulocyte colony-stimulating factor(G-CSF)

Total 14332 results

Heinrich-Heine University, Duesseldorf
Chugai Pharma USA; Terumo BCT

Completed

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia® (optiMaL)

Healthy Allogeneic Donors | Granulocyte Colony-stimulating Factor (G-CSF) Mobilized

Germany
Sun Yat-sen University

Recruiting

PD-1 Inhibitor Plus G-CSF in Recurrent/Metastatic NPC With First-line Treatment Failure

PD-1 Inhibitor | G-CSF

China
TECAM Group
Hospital General Universitario Gregorio Marañon

Unknown

Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction (TECAM2)

Reperfused Acute Myocardial Infarction

Spain
Catholic University of the Sacred Heart

Withdrawn

RIGENERA 2.0 Trial (RIGENERA)

Heart Failure | Anterior Myocardial Infarction

Italy
Chang Gung Memorial Hospital

Recruiting

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Neutropenia | Pediatric Cancer | G-CSF | Lenograstim | Filgrastim

Taiwan
Postgraduate Institute of Medical Education and...

Unknown

Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis (G-CSF)

Liver Failure, Acute

India
Dong-A ST Co., Ltd.

Completed

Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia (PEG-G-CSF)

Chemotherapy Induced Neutropenia

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia (PEG-G-CSF)

Chemotherapy Induced Neutropenia

Korea, Republic of
DERSHENG SUN

Unknown

Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)

Neutropenia

Korea, Republic of
PETHEMA Foundation

Terminated

A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF

Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF

Spain
University of South Florida

Completed

Efficacy and Safety of Filgrastim in Alzheimer's Disease (FFAD)

Alzheimer's Disease

United States
Institute of Hematology & Blood Diseases Hospital

Recruiting

A Study of PEG-rhG-CSF and rhG-CSF Used for Aplastic Anemia Granulocyte Deficiency

Severe Aplastic Anemia

China
Hospital Sao Rafael

Completed

Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy

Chronic Chagasic Myocarditis

Brazil
Emory University

Terminated

A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

Hematologic Diseases

United States
Turkish Leukemia Study Group

Completed

Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML (TLG-AML-95-002)

AML
Mylan Inc.
Mylan GmbH

Completed

Efficacy and Safety Study With MYL-1401H and Neulasta

Breast Neoplasms | Chemotherapy-Induced Febrile Neutropenia

Bulgaria, Georgia, Germany, Hungary, Poland, Ukraine
Emory University

Completed

Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)

Hematologic Diseases | Hematologic Malignancies

United States
Govind Ballabh Pant Hospital

Unknown

Granulocyte Colony Stimulating Factor(G-CSF) Therapy for Patients With ACLF

Acute on Chronic Liver Failure

India
Centre Georges Francois Leclerc

Completed

Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin (EMEG-E-01)

Breast Cancer

France
Gurgan Clinic

Completed

Intrauterine G-CSF Administration in RIF (G-CSF)

Infertility

Turkey
Dana-Farber Cancer Institute

Completed

Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT

Multiple Myeloma

United States
Alberta Health services

Completed

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Peripheral Stem Cell/Marrow Transplant

Canada
Emory University

Terminated

G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome (G-CSF PMRD)

Hematologic Malignancies

United States
Ottawa Hospital Research Institute

Recruiting

Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy (REaCT-OGF)

Early-stage Breast Cancer

Canada
St. Bartholomew's Hospital

Unknown

Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

United Kingdom
Genzyme, a Sanofi Company

Approved for marketing

Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization (CUP)

Autologous Stem Cell Transplant
Hematology department of the 920th hospital

Recruiting

A Clinical Study of VA-CAG as Induction Therapy in Newly Diagnosed AML Patients

Acute Myeloid Leukemia

China
University of Leipzig

Completed

Granulocyte Colony Stimulating Factor (G-CSF) to Treat Acute-on-chronic Liver Failure

Acute-On-Chronic Liver Failure

Germany
Seoul National University Hospital

Terminated

Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion

Myocardial Infarction

Korea, Republic of
Zhongnan Hospital

Not yet recruiting

The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

Granulocyte Colony-Stimulating Factor

China
Fakultas Kedokteran Universitas Indonesia
Dr Cipto Mangunkusumo General Hospital

Completed

Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation

Liver Cirrhosis | Undernutrition | Severe Malnutrition | PELD

Indonesia
M.D. Anderson Cancer Center
Genzyme, a Sanofi Company

Completed

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

Leukemia | Stem Cell Transplantation

United States
Beijing 302 Hospital

Unknown

RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure

Liver Failure | Hepatitis B | Alcoholic Liver Disease

China
Seoul St. Mary's Hospital

Unknown

Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML (DeGREE)

Leukemia, Myeloid, Acute

Korea, Republic of
Hanyang University Seoul Hospital
Ministry of Health & Welfare, Korea

Completed

Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells

Cerebral Palsy | Neurodegeneration | G-CSF | Peripheral Blood Mononuclear Cells
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Lymphoma | Multiple Myeloma

Australia
Shiraz University of Medical Sciences

Completed

The Effect of Granulocyte Colony Stimulating Factor (G-CSF) on Myocardial Function After Acute Anterior Myocardial Infarction, a Prospective Double Blind Randomized Placebo Controlled Study

Myocardial Infarction

Iran, Islamic Republic of
Shandong University

Unknown

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Acute Myeloid Leukemia

China
Mylan Inc.
Mylan GmbH

Completed

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

Healthy Volunteers

Netherlands
Washington University School of Medicine
Millennium Pharmaceuticals, Inc.

Completed

Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

Multiple Myeloma

United States
GPCR Therapeutics, Inc.

Completed

PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Multiple Myeloma | Hodgkin Disease | Non-Hodgkin Lymphoma

United States
Centre for Endocrinology and Reproductive Medicine...

Unknown

Use of G-CSF Supplemented IVF Medium in Patients Undergoing IVF

Infertility | Embryo Development | IVF

Italy
Dartmouth-Hitchcock Medical Center
Amgen

Terminated

Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function

Metastatic Breast Cancer
Hyuk moon Kim
Dong-A Pharmaceutical Co., Ltd.

Unknown

Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

Neutropenia

Korea, Republic of
M.D. Anderson Cancer Center
Bayer

Completed

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients

Lymphoma

United States
University Hospital Muenster

Completed

Influence of G-CSF and EPO on Associative Learning and Motor Skills

Amyotrophic Lateral Sclerosis | Chronic Stroke

Germany
National Institutes of Health Clinical Center (CC)

Completed

G-CSF for Granulocyte Donation

Healthy

United States
Washington University School of Medicine

Completed

Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

Stem Cell Transplant Patients

United States
Washington University School of Medicine

Completed

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin | Multiple Myeloma

United States
European Society for Blood and Marrow Transplantation
CHUGAI sanofi-aventis

Terminated

Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) (SAA-G-CSF)

Aplastic Anaemia

France, Netherlands, Germany, United Kingdom, Switzerland, Italy, Sweden, Greece, Czechia

3

Subscribe